Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Certain diets can affect skin conditions, but more research is needed to understand these relationships fully.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Aging in hair follicle stem cells leads to hair graying, thinning, and loss.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Minoxidil effectively treats female pattern hair loss.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Ketoconazole shampoo with finasteride improves hair density in men with hair loss.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.